AM Best Revises Outlooks to Positive for The Doctors Company and Subsidiaries
AM Best has revised the outlooks to positive from stable and affirmed The Doctors Company's financial strength rating (FSR) of A (Excellent) and the long-term issuer credit rating (ICR) of "a+”. The positive outlooks, FSR of A, and long-term ICR of “a+” have been affirmed for The Doctors Company, an Interinsurance Exchange, and its core subsidiaries, which collectively comprise The Doctors Company Insurance Group (TDC or TDC Group).
Search
Exclusively Sponsored by the American Association of Neurological Surgeons
The American Association of Neurological Surgeons exclusively sponsors The Doctors Company. AANS members receive unique benefits, including exclusive program discounts and credits.
October 01, 2025, Cardiology Magazine
Incidental Findings in Cardiac Imaging: Clinical Opportunity or Legal Liability?
Advances in cardiac imaging technology are leading to increased detection of incidental, noncardiac abnormalities within scanned areas. Pulmonary nodules are one of the most common incidental findings. If the ordering practitioner does not follow up, an incidental finding may lead to patient harm and result in a malpractice claim.
The Malpractice Experience of Obstetricians with Shoulder Dystocia: Preparation May Mitigate Risks With This Unpredictable Event
Shoulder dystocia (SD) is a rare complication of vaginal delivery. The purpose of this study was to better understand factors that may contribute to medical malpractice claims with SD and to offer recommendations to practicing obstetricians regarding the management of SD.
The Doctors Company and ProAssurance Announce Early Termination of the Hart-Scott-Rodino Waiting Period
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, and ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical liability, products liability for medical technology and life sciences, and workers’ compensation insurance, announced today that on July 2, 2025, the U.S. Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) with respect to the pending acquisition of ProAssurance by The Doctors Company.
Professional Education
Module 4: Recognition, Diagnosis, and Treatment of Substance Use Disorder (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will be shown strategies for recognizing substance use disorder (SUD) and opioid use disorder (OUD). Refamiliarize yourself with screening for fentanyl. Provide valuable pharmacological and nonpharmacological resources to connect patients to treatment for addiction. Discuss individualized treatment plans that are tailored to specific patient needs when treating OUD. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Jun 18, 2024
Spotlight on Foundation Grants: Using AI to Assess Cataract Surgery Performance
The Doctors Company Foundation highlights a project to develop an AI system for assessing surgical competency in cataract surgery.
From
The Doctor’s Advocate
Social Inflation Causes Between $2.4 and $3.5 Billion of All Medical Malpractice Losses, The Doctors Company Study Finds
In the decade ending in 2021, between $2.4 and $3.5 billion, or 8 to 11 percent, of all medical malpractice losses incurred by physician-focused insurers stemmed from social inflation, according to new research from The Doctors Company, the nation’s largest physician-owned medical malpractice insurer and part of TDC Group.
Resources for Practice Managers
Get all our expert resources on important practice management topics, including OSHA standards, compliance, training, checklists, and tools.
October 16, 2022, The Art of Medicine with Dr. Andrew Wilner
Avoiding Medical Malpractice: An Interview with David Feldman, MD, MBA
Dr. David L. Feldman, Chief Medical Officer for The Doctors Company, speaks with Andrew Wilner, MD, FACP, FAAN, Associate Professor of Neurology, The University of Tennessee Health Science Center, on ways to improve patient outcomes and prevent medical malpractice.
